Skip to main content
logo
Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.0406
+0.0056 (16.00%)
At close: Aug 14, 2026

Bio-Path Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-5.39-8.33-11.99-15.84-13.9-10.44
Net Income
-6.09-8.67-9.89-16.08-13.87-10.44
Earnings Per Share
-0.72-1.10-4.12-33.64-38.12-31.05
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.0101.171.0510.3823.77
Total Debt
0.510.460.080.110.220.24
Net Cash (Debt)
-0.5-0.461.090.9410.1623.54
Net Cash Growth
--16.08%-90.76%-56.83%75.34%
Net Cash Per Share
-0.06-0.060.451.9627.9270.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.32-1.6-10.58-11.54-15.1-9.92
Capital Expenditures
-----0.02-0.07
Free Cash Flow
-0.32-1.6-10.58-11.54-15.12-9.99
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-7.067.067.067.067.06
PS Ratio
------